In 2019, Mayor Muriel Bowser proposed the Safe Cannabis Sales Act, a significant legislative move aimed at regulating the sale of recreational cannabis in Washington D.C. This bill not only aims to enhance public safety and health but also provides clear guidelines on the use of cannabis and cannabis products. A key focus of the legislation is to advance equity, particularly benefiting communities that have been disproportionately affected by the criminalization of cannabis.
The Safe Cannabis Sales Act of 2019 emphasizes creating a legal and secure marketplace for cannabis. This move is expected to reduce the demand for illegal drugs, which are often associated with violence in neighborhoods. Furthermore, it ensures that cannabis sold in regulated establishments is free from harmful chemicals and pesticides.
Mayor Bowser’s administration has been actively involved in outlining changes in District marijuana laws, including those related to medical marijuana. The Medical Cannabis Amendment Act of 2022, signed into law in January 2023, overhauls D.C.’s medical cannabis program. This program serves a substantial number of both D.C. and non-D.C. resident patients.
The legislation also includes provisions for public education about cannabis use and the law, establishing a 13% tax on the sale of recreational cannabis, and measures to prohibit discrimination against individuals who engage in lawful cannabis use. Additionally, there are initiatives for the expungement of cannabis-related arrests and convictions.
While the legislation permits the possession and use of marijuana for adults aged 21 and older, it still prohibits consumption in public spaces, selling marijuana, and operating vehicles or boats under the influence of marijuana.
Overall, the introduction of the Safe Cannabis Sales Act of 2019 and subsequent amendments reflect a significant shift in marijuana legislation in Washington D.C., focusing on safety, equity, and public health.
